3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508delCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorderActive, not recruitingPhase 32026-10-09NCT05331183
BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma Non-resectableRecruitingNot applicable2026-07-10NCT05911633
Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal AdenocarcinomaBarrett esophagus, Digestive System Diseases, digestive system disorder, esophageal disorder, neoplasm, precancerous conditionRecruitingNot applicable2024-07-24NCT03222635